Dr. Vijayvergia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 cottman avenue
Philadelphia, PA 19111
Education & Training
- Fox Chase Cancer Center2012 - 2015
- Temple University HospitalResidency, Internal Medicine, 2009 - 2011
- Temple University HospitalInternship, Internal Medicine, 2008 - 2009
- Jawaharlal Nehru Medical CollegeClass of 2007
Certifications & Licensure
- PA State Medical License 2008 - 2024
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Awarded "NANETS Annual Symposium 2014 Travel Grant" 2014
- Awarded "National Pancreas Foundation Fellowship Symposium Travel Grant" 2014
- Abstract awarded 2nd place ACP Pennsylvania Southeastern Region's Abstract Competition, 2011
- Join now to see all
Clinical Trials
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Start of enrollment: 2018 Oct 26
- Organ Preservation in Early Rectal Cancer Patients Start of enrollment: 2018 May 11
Publications & Presentations
PubMed
- TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.Patrick M Boland, Sarbajit Mukherjee, Iman Imanirad, Namrata Vijayvergia, Seth D Cohen
British Journal of Cancer. 2024-11-01 - Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu
Journal of Clinical Oncology. 2024-09-20 - 1 citationsPhase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.Jennifer A Chan, Susan Geyer, Tyler Zemla, Michael V Knopp, Spencer Behr
The New England Journal of Medicine. 2024-09-16
Journal Articles
- Differences in patterns of care and outcomes of elderly versus younger metastatic pancreatic cancer (mPC) patientsVijayvergia, N., Dotan, E., Cohen, S.J., J Clin Oncol, 1/1/2013
- Diagnostic Approach to a Patient with Paraneoplastic Neurological SyndromeMahta, A., Vijayvergia, N.,Ward, L. D., World Journal of Oncology, 1/1/2012
Abstracts/Posters
- "NUT Midline Carcinomas"Namrata (Neena) Vijayvergia, MD, Multidisciplinary Oncology Case Conference, Temple University Hospital, Philadelphia, 1/1/2013
- "Thrombotic Microangiopathy: A Focus on Atypical HUS"Namrata (Neena) Vijayvergia, MD, Case Based Hematology Conference, Temple University Hospital, Philadelphia, 1/1/2013
- "Hereditary Breast Cancer"Namrata (Neena) Vijayvergia, MD, Fellows Case Conference, Fox Chase Cancer Center, 1/1/2012
- Join now to see all
Lectures
- "Chronic Myelogenous Leukemia: Chronic malignancy in true sense?"Temple University Hospital, Philadelphia - 1/1/2014
- "Medical management of Locally Advanced Esophageal Cancer"Fox Chase Cancer Center - 1/1/2013
- "Chemotherapy in Pancreatic Cancer: Where we are and where we are heading"Fox Chase Cancer Center - 1/1/2013
Press Mentions
- ORYZON Announces First Patient in in NET, a Collaborative Phase II Basket Study with Iadademstat in R/R Patients with Neuroendocrine CarcinomasJanuary 18th, 2023
- Pitching a Perfect Game Against Pancreatic CancerSeptember 18th, 2019
- Resolve to Reduce Your Cancer Risk This YearJanuary 3rd, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: